Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
24 results for “clinical-trials”
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
What does the new government mean for cannabis policy in the UK?
The CRDG will set out the country’s first comprehensive strategy for cannabinoid research and development.
Kerry Davies shares how medicinal cannabis helps her manage the symptoms of fibromyalgia, anxiety and depression.
A new report highlights the breakthroughs and barriers in the pharmaceutical cannabis space over the last 13 years.
The findings of the review will inform a future RCT looking at the tolerability of cannabinoids in children with cancer.
Your weekly debrief of the latest cannabis news.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
The Australian study is expected to be the world’s largest on the health economic impact of medical cannabis.
Your weekly debrief of the latest cannabis news.
Pain is the most common indication to be studied in cannabinoid clinical trials since 2010, says an upcoming report.
Experts say allowing GPs to initiate cannabis prescriptions would open up access in the UK.
Following a ‘positive’ inaugural meeting, concerns remain over the appointment of the Advisory Support Group.
Advocates in the UK are calling for their own government to follow suit and invest in much-needed NHS trials.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.
Researchers at the University of Edinburgh have received £1.55 million in grant funding for two Phase II clinical trials.
Bruce Kendall and Professor Hinanit Koltai share the remarkable story behind a promising new study.
Researchers found limited evidence, however, to support its efficacy at doses lower than 400mg.
Having the right software is a must, writes Miguel Fagundes, chief technical officer at Eurocan.
The Cannabis Directory aims to link patients directly with trusted clinicians.
The trial has been carried out by Radicle Science and Open Book Extracts.